Viral MHC class I-like molecule allows evasion of NK cell effector responses in vivo

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 6061-6069

  Pyzik, Michal ^a,b,e   Dumaine, Anne A ^a,b   Charbonneau, Benoît ^a,b   Fodil Cornu, Nassima ^a,b   Jonjic, Stipan ^c   Vidal, Silvia M ^a,b,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF RIJEKA   (Croatia)

^d MCGILL UNIVERSITY   (Canada)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN M157; UNCLASSIFIED DRUG; VIRUS PROTEIN; H2 ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL EXPANSION; CELL KILLING; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HAPLOTYPE; IMMUNE EVASION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION SENSITIVITY; MOLECULAR MIMICRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; STRAIN DIFFERENCE; VIRUS REPLICATION; ANIMAL; CELL LINE; CYTOTOXICITY; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; INBRED MOUSE STRAIN; METABOLISM; MUROMEGALOVIRUS; PATHOGENICITY; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; H-2 ANTIGENS; HERPESVIRIDAE INFECTIONS; KILLER CELLS, NATURAL; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; VIRAL PROTEINS;

EID: 84916910712     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401386     Document Type: Article

References (50)

1. Babić, M., A. Krmpotić, and S. Jonjić. 2011. All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends Mol. Med. 17: 677-685.
2. Champsaur, M., and L. L. Lanier. 2010. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 235: 267-285.
3. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
4. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
5. Lee, S. H., S. Girard, D. Macina, M. Busà, A. Zafer, A. Belouchi, P. Gros, and S. M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28: 42-45.
6. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
7. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194: 29-44.
8. Desrosiers, M. P., A. Kielczewska, J. C. Loredo-Osti, S. G. Adam, A. P. Makrigiannis, S. Lemieux, T. Pham, M. B. Lodoen, K. Morgan, L. L. Lanier, and S. M. Vidal. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37: 593-599.
9. Kielczewska, A., M. Pyzik, T. Sun, A. Krmpotic, M. B. Lodoen, M. W. Munks, M. Babic, A. B. Hill, U. H. Koszinowski, S. Jonjic, et al. 2009. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 206: 515-523.
10. Pyzik, M., B. Charbonneau, E. M. Gendron-Pontbriand, M. Babić, A. Krmpotić, S. Jonjić, and S. M. Vidal. 2011. Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains. J. Exp. Med. 208: 1105-1117.
11. Arase, H., and L. L. Lanier. 2002. Virus-driven evolution of natural killer cell receptors. Microbes Infect. 4: 1505-1512.
12. Adams, E. J., Z. S. Juo, R. T. Venook, M. J. Boulanger, H. Arase, L. L. Lanier, and K. C. Garcia. 2007. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 104: 10128-10133.
13. McVicar, D. W., R. Winkler-Pickett, L. S. Taylor, A. Makrigiannis, M. Bennett, S. K. Anderson, and J. R. Ortaldo. 2002. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J. Immunol. 169: 1721-1728.
14. Patel, R., S. Bélanger, L. H. Tai, A. D. Troke, and A. P. Makrigiannis. 2010. Effect of Ly49 haplotype variance on NK cell function and education. J. Immunol. 185: 4783-4792.
15. Corbett, A. J., J. D. Coudert, C. A. Forbes, and A. A. Scalzo. 2011. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. J. Immunol. 186: 1713-1722.
16. Berry, R., N. Ng, P. M. Saunders, J. P. Vivian, J. Lin, F. A. Deuss, A. J. Corbett, C. A. Forbes, J. M. Widjaja, L. C. Sullivan, et al. 2013. Targeting of a natural killer cell receptor family by a viral immunoevasin. Nat. Immunol. 14: 699-705.
17. Orr, M. T., W. J. Murphy, and L. L. Lanier. 2010. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11: 321-327.
18. Babić, M., M. Pyzik, B. Zafirova, M. Mitrović, V. Butorac, L. L. Lanier, A. Krmpotić, S. M. Vidal, and S. Jonjić. 2010. Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J. Exp. Med. 207: 2663-2673.
19. Tripathy, S. K., P. A. Keyel, L. Yang, J. T. Pingel, T. P. Cheng, A. Schneeberger, and W. M. Yokoyama. 2008. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205: 1829-1841.
20. Bubić, I., M. Wagner, A. Krmpotić, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjić and U. H. Koszinowski. 2004. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78: 7536-7544.
21. Fodil-Cornu, N., S. H. Lee, S. Belanger, A. P. Makrigiannis, C. A. Biron, R. M. Buller, and S. M. Vidal. 2008. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J. Immunol. 181: 6394-6405.
22. Kielczewska, A., H. S. Kim, L. L. Lanier, N. Dimasi, and S. M. Vidal. 2007. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class Ilike protein. J. Immunol. 178: 369-377.
23. Lenac, T., M. Budt, J. Arapovic, M. Hasan, A. Zimmermann, H. Simic, A. Krmpotic, M. Messerle, Z. Ruzsics, U. H. Koszinowski, et al. 2006. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203: 1843-1850.
24. Dong, Z., M. E. Cruz-Munoz, M. C. Zhong, R. Chen, S. Latour, and A. Veillette. 2009. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat. Immunol. 10: 973-980.
25. Ljunggren, H. G., and K. Kärre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162: 1745-1759.
26. Pyzik, M., A. Kielczewska, and S. M. Vidal. 2008. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Semin. Immunol. 20: 331-342.
27. Hanke, T., H. Takizawa, C. W. McMahon, D. H. Busch, E. G. Pamer, J. D. Miller, J. D. Altman, Y. Liu, D. Cado, F. A. Lemonnier, et al. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
28. Hasan, M., A. Krmpotic, Z. Ruzsics, I. Bubic, T. Lenac, A. Halenius, A. Loewendorf, M. Messerle, H. Hengel, S. Jonjic, and U. H. Koszinowski. 2005. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J. Virol. 79: 2920-2930.
29. Jonjić, S., M. Babić, B. Polić, and A. Krmpotić. 2008. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20: 30-38.
30. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8: 259-268.
31. Abi-Rached, L., and P. Parham. 2005. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 201: 1319-1332.
32. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
33. Smith, L. M., A. R. McWhorter, L. L. Masters, G. R. Shellam, and A. J. Redwood. 2008. Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus. J. Virol. 82: 6689-6696.
34. Andrews, D. M., M. J. Estcourt, C. E. Andoniou, M. E. Wikstrom, A. Khong, V. Voigt, P. Fleming, H. Tabarias, G. R. Hill, R. G. van der Most, et al. 2010. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207: 1333-1343.
35. Mitrović, M., J. Arapović, S. Jordan, N. Fodil-Cornu, S. Ebert, S. M. Vidal, A. Krmpotić, M. J. Reddehase, and S. Jonjić. 2012. The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response. J. Virol. 86: 2165-2175.
36. Ochi, H., and T. Watanabe. 2000. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. Int. Immunol. 12: 1417-1423.
37. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
38. Choi, Y. S., and N. Baumgarth. 2008. Dual role for B-1a cells in immunity to influenza virus infection. J. Exp. Med. 205: 3053-3064.
39. Schneider, K., A. Loewendorf, C. De Trez, J. Fulton, A. Rhode, H. Shumway, S. Ha, G. Patterson, K. Pfeffer, S. A. Nedospasov, et al. 2008. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3: 67-76.
40. Jonjić, S., I. Pavić, B. Polić, I. Crnković, P. Lucin, and U. H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179: 1713-1717.
41. Brodin, P., T. Lakshmikanth, R. Mehr, M. H. Johansson, A. D. Duru, A. Achour, M. Salmon-Divon, K. Kärre, P. Höglund, and S. Johansson. 2010. Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice. PLoS ONE 5: e13174.
42. Wilkinson, G. W., P. Tomasec, R. J. Stanton, M. Armstrong, V. Prod'homme, R. Aicheler, B. P. McSharry, C. R. Rickards, D. Cochrane, S. Llewellyn-Lacey, et al. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41: 206-212.
43. Reyburn, H. T., O. Mandelboim, M. Valés-Gómez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386: 514-517.
44. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282.
45. Leong, C. C., T. L. Chapman, P. J. Bjorkman, D. Formankova, E. S. Mocarski, J. H. Phillips, and L. L. Lanier. 1998. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187: 1681-1687.
46. Kaiser, B. K., J. C. Pizarro, J. Kerns, and R. K. Strong. 2008. Structural basis for NKG2A/CD94 recognition of HLA-E. Proc. Natl. Acad. Sci. USA 105: 6696-6701.
47. Béziat, V., L. L. Liu, J. A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
48. Meyer-König, U., K. Ebert, B. Schrage, S. Pollak, and F. T. Hufert. 1998. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 352: 1280-1281.
49. Thielens, A., E. Vivier, and F. Romagné. 2012. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr. Opin. Immunol. 24: 239-245.
50. Bashirova, A. A., R. Thomas, and M. Carrington. 2011. HLA/KIR restraint of HIV: surviving the fittest. Annu. Rev. Immunol. 29: 295-317.